Intraoperative Liver Biopsy During Adolescent Bariatric Surgery: Is It Really Necessary?


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 26 8 2019
medline: 20 8 2020
entrez: 26 8 2019
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is prevalent in children with obesity and is definitively diagnosed with liver biopsy. However, the utility of routine biopsy during adolescent bariatric surgery remains unknown. We describe the usefulness of routine versus selective intraoperative liver biopsy in adolescents undergoing bariatric surgery. A retrospective review of adolescents who received bariatric surgery at our institution between 2007 and 2018 was performed. Prior to 2014, all patients routinely received intraoperative liver biopsy. After 2014, biopsy was performed selectively on an individual basis for transaminitis or clinical concern. Demographic, biochemical, and histopathologic data were compared between patients who underwent routine, selective, or no biopsy. There were 77 patients who received bariatric surgery during the study period: 32 underwent routine biopsy, 13 selective biopsy, and 32 no biopsy. Selective liver biopsy was more likely to show pathologic evidence of fibrosis (84.6% versus 31.2%, p = 0.000) and steatosis (100.0% versus 59.4%, p = 0.003), and higher mean NAFLD activity score compared with routine biopsies (4.4 versus 2.1, p = 0.001). Patients with steatosis had significantly higher preoperative fasting insulin (41.4 versus 21.1 mIU/L, p = 0.000), and patients with fibrosis had significantly higher glycated hemoglobin (6.1% versus 5.5%, p = 0.033) and alanine aminotransferase (81.5 versus 52.7 mg/dL, p = 0.043). There were no biopsy complications or changes in management due to biopsy results. Routine intraoperative liver biopsy during adolescent bariatric surgery possesses questionable benefit, as it does not appear to impact short-term postoperative management. Prospective, longitudinal studies are needed to better understand the meaningfulness of liver histopathology in this population.

Sections du résumé

BACKGROUND
Nonalcoholic fatty liver disease (NAFLD) is prevalent in children with obesity and is definitively diagnosed with liver biopsy. However, the utility of routine biopsy during adolescent bariatric surgery remains unknown. We describe the usefulness of routine versus selective intraoperative liver biopsy in adolescents undergoing bariatric surgery.
METHODS
A retrospective review of adolescents who received bariatric surgery at our institution between 2007 and 2018 was performed. Prior to 2014, all patients routinely received intraoperative liver biopsy. After 2014, biopsy was performed selectively on an individual basis for transaminitis or clinical concern. Demographic, biochemical, and histopathologic data were compared between patients who underwent routine, selective, or no biopsy.
RESULTS
There were 77 patients who received bariatric surgery during the study period: 32 underwent routine biopsy, 13 selective biopsy, and 32 no biopsy. Selective liver biopsy was more likely to show pathologic evidence of fibrosis (84.6% versus 31.2%, p = 0.000) and steatosis (100.0% versus 59.4%, p = 0.003), and higher mean NAFLD activity score compared with routine biopsies (4.4 versus 2.1, p = 0.001). Patients with steatosis had significantly higher preoperative fasting insulin (41.4 versus 21.1 mIU/L, p = 0.000), and patients with fibrosis had significantly higher glycated hemoglobin (6.1% versus 5.5%, p = 0.033) and alanine aminotransferase (81.5 versus 52.7 mg/dL, p = 0.043). There were no biopsy complications or changes in management due to biopsy results.
CONCLUSIONS
Routine intraoperative liver biopsy during adolescent bariatric surgery possesses questionable benefit, as it does not appear to impact short-term postoperative management. Prospective, longitudinal studies are needed to better understand the meaningfulness of liver histopathology in this population.

Identifiants

pubmed: 31446562
doi: 10.1007/s11695-019-04136-4
pii: 10.1007/s11695-019-04136-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-76

Références

Surg Obes Relat Dis. 2012 Mar-Apr;8(2):133-7; discussion 137-9
pubmed: 22433934
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Gastroenterology. 2015 Sep;149(3):623-34.e8
pubmed: 26026390
J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):188-192
pubmed: 29356764
BMC Pediatr. 2017 Apr 26;17(1):113
pubmed: 28446162
Obes Surg. 2016 Jan;26(1):177-81
pubmed: 26428254
Pediatr Obes. 2014 Oct;9(5):e91-3
pubmed: 24677740
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
J Pediatr Surg. 2012 Sep;47(9):1633-9
pubmed: 22974598
Surg Obes Relat Dis. 2015 Mar-Apr;11(2):442-9
pubmed: 25820083
Surg Obes Relat Dis. 2017 Oct;13(10):1780-1786
pubmed: 28935200
Obesity (Silver Spring). 2013 Mar;21(3):591-7
pubmed: 23592668
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334
pubmed: 28107283
Curr Gastroenterol Rep. 2016 May;18(5):24
pubmed: 27086005
Semin Pediatr Surg. 2014 Feb;23(1):49-57
pubmed: 24491369
Obes Rev. 2017 Sep;18(9):1050-1060
pubmed: 28544608
Gastroenterol Hepatol (N Y). 2018 Jul;14(7):407-414
pubmed: 30166956
Hepatology. 2017 Jun;65(6):2100-2109
pubmed: 28103626

Auteurs

R Ellen Jones (RE)

Department of Surgery, Division of Pediatric Surgery, Stanford University Medical Center, 300 Pasteur Dr Rm M116, Alway Bldg MC 5733, Stanford, CA, 94305, USA.

Ann Ming Yeh (AM)

Department of Pediatrics, Division of Gastroenterology, Stanford University Medical Center, Stanford, CA, USA.

Neerajah Kambham (N)

Department of Clinical Pathology, Stanford University Medical Center, Stanford, CA, USA.

Marwa Abu El Haija (MA)

Department of Pediatrics, Division of Gastroenterology, Stanford University Medical Center, Stanford, CA, USA.

Janey Pratt (J)

Department of Surgery, Division of Pediatric Surgery, Stanford University Medical Center, 300 Pasteur Dr Rm M116, Alway Bldg MC 5733, Stanford, CA, 94305, USA.

Matias Bruzoni (M)

Department of Surgery, Division of Pediatric Surgery, Stanford University Medical Center, 300 Pasteur Dr Rm M116, Alway Bldg MC 5733, Stanford, CA, 94305, USA. mbruzoni@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH